A Phase IV Study in Drug-Naive Patients With T2DM in China
Condition: Type 2 Diabetes Mellitus Interventions: Drug: Dapagliflozin; Drug: Acarbose Sponsor: AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials